Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 76 - 100 of 338 in total
Sub Class LM ID Name ▲ LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Diacylglycerophosphoinositolglycans LMGP15010091
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/18:1(9Z))
126457459 1200.678433 C58H105O23P
Diacylglycerophosphoinositolglycans LMGP15010087
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/16:0)
126457455 1174.662783 C56H103O23P
Diacylglycerophosphoinositolglycans LMGP15010090
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/18:0)
126457458 1202.694083 C58H107O23P
Diacylglycerophosphoinositolglycans LMGP15010086
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(19:1(9Z)/14:0)
126457454 1146.631483 C54H99O23P
Monoacylglycerophosphoinositolglycans LMGP15040015
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM2(19:1(9Z)/0:0)
126457672 936.433118 C40H73O22P
Diacylglycerophosphoinositolglycans LMGP15010071
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/16:2(9Z,12Z))
126457439 1156.615833 C55H97O23P
Diacylglycerophosphoinositolglycans LMGP15010070
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/16:1(9Z))
126457438 1158.631483 C55H99O23P
Diacylglycerophosphoinositolglycans LMGP15010073
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/18:1(9Z))
126457441 1186.662783 C57H103O23P
Diacylglycerophosphoinositolglycans LMGP15010069
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/16:0)
126457437 1160.647133 C55H101O23P
Diacylglycerophosphoinositolglycans LMGP15010072
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/18:0)
126457440 1188.678433 C57H105O23P
Diacylglycerophosphoinositolglycans LMGP15010068
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(18:1(9Z)/14:0)
126457436 1132.615833 C53H97O23P
Monoacylglycerophosphoinositolglycans LMGP15040012
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM2(18:1(9Z)/0:0)
126457669 922.417468 C39H71O22P
Diacylglycerophosphoinositolglycans LMGP15010059
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/16:2(9Z,12Z))
126457427 1144.615833 C54H97O23P
Diacylglycerophosphoinositolglycans LMGP15010058
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/16:1(9Z))
126457426 1146.631483 C54H99O23P
Diacylglycerophosphoinositolglycans LMGP15010061
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/18:1(9Z))
126457429 1174.662783 C56H103O23P
Diacylglycerophosphoinositolglycans LMGP15010057
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/16:0)
126457425 1148.647133 C54H101O23P
Diacylglycerophosphoinositolglycans LMGP15010060
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/18:0)
126457428 1176.678433 C56H105O23P
Diacylglycerophosphoinositolglycans LMGP15010056
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(17:0/14:0)
126457424 1120.615833 C52H97O23P
Monoacylglycerophosphoinositolglycans LMGP15040010
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM2(17:0/0:0)
126457667 910.417468 C38H71O22P
Diacylglycerophosphoinositolglycans LMGP15010053
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/16:2(9Z,12Z))
126457421 1130.600183 C53H95O23P
Diacylglycerophosphoinositolglycans LMGP15010052
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/16:1(9Z))
126457420 1132.615833 C53H97O23P
Diacylglycerophosphoinositolglycans LMGP15010055
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/18:1(9Z))
126457423 1160.647133 C55H101O23P
Diacylglycerophosphoinositolglycans LMGP15010054
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/18:0)
126457422 1162.662783 C55H103O23P
Diacylglycerophosphoinositolglycans LMGP15010050
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM2(16:0/14:0)
126457418 1106.600183 C51H95O23P
Monoacylglycerophosphoinositolglycans LMGP15040009
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM2(16:0/0:0)
126457666 896.401818 C37H69O22P

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024